The LDN Research Trust New Horizons: Celebrating 20 Years – The New Book

The LDN 20-Year Anniversary Book is finally here!

Low Dose Naltrexone (LDN) Testimonials come together to help celebrate the 20-year anniversary of the LDN Research Trust.

New Horizons is a book to celebrate the 20th Anniversary of the LDN Research Trust, which is a nonprofit charity. The book contains LDN testimonials from LDN prescribers, pharmacists, researchers, and Patients from around the world to share their testimonials.

Key 2024 awareness dates and talking points relating to the book & author:

• LDN Conference 2024 – https://www.ldnrtevents.com/
• MS Awareness Week – 24–30 April
• ME/CFS International Awareness Day – 12 May
• Mental Health Awareness Week – 15-21 May
• Long Covid Awareness Day – 9 June
• Men’s Health Week – 12-18 June
• The LDN Awareness Week – 23-25 June 2024
• Mold Awareness Month – September
• World Mental Health Day – 10 October

Praise for the LDN Book 3:
“LDN Book 3 has a valuable contribution to make in pushing the boundaries of contemporary medicine whilst inviting greater research that may bring this therapy into the evidence-based world of normal day to day medical practice.”
– Dr Tony Jones, FRCGP, Clinical Director Maidstone Central PCN

“This book is gold! It is a science-based, effective solution to the rampant chronic health problems that plague millions today. It is easy to understand, simple to implement, and most importantly, will be a guiding light for so many who are out of answers and are desperately searching for a path home to health.”
– Dr. Mindy Pelz, DC, Bestselling author of The Reset Factor, The Reset Factor Kitchen, and The Menopause Reset

“The LDN Book 3 gives valuable insight into the drug of the decade. The immense knowledge within can change and improve the quality of life. For many, it’s a game changer.” – Nat Jones, R.Ph. FAPC, Clinical Compounding Pharmac

About Linda Elsegood
Linda Elsegood discovered LDN after relapsing/remitting MS, which caused her to have attacks every six
months. It took months for a relapse to recede, only to have another begin. In October 2003, Linda was advised she had secondary progressive MS and there was nothing anyone could do to help her, and like so many people sought alternative options for her own healthcare. Following her success with LDN, Linda Elsegood founded the LDN Research Trust as a UK nonprofit registered charity in 2004. The LDN Research Trust (www.ldnresearchtrust.org) is run by volunteers; they receive no funding and rely on donations. The team liaises closely with prescribers, pharmacists, and patients, offering support and education. The charity’s website has become a go-to resource for patients and medical professionals seeking the latest information on clinical trials and studies involving LDN, conditions for which LDN is used, global LDN prescribers and pharmacists, prescriber/patient guides, and more. They have their own LDN Radio Show, which listeners can access on Mixcloud, Captivate FM, Google, Apple & Amazon Podcast, iTunes, and Spotify in addition to Vimeo and YouTube. Six documentaries have also been produced with significant reach and success. In June 2023, the LDN Research Trust annual LDN conference will be held in the United States, and seminars, workshops and smaller events are arranged regularly to help build awareness and education, and to encourage and support ongoing research about LDN.